Northwest Biotherapeutics, Inc. NWBO
0.17 USD +0.01 (+6.25%)
At closeNov 6, 2026, 4:00 PM EST
0.163 Day range 0.1698
0.15 52-week range 0.32
- YTD
- -26.09%
- 1 year
- -29.17%
Analyst view
Consensus: buy
Buy
Price target (mean) 5.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 312.62M | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 312.62M | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 312.62M | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 692.15M | +121.4% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 11, 2014 | Oppenheimer | Downgrade | Outperform | Perform |
| Oct 15, 2013 | Oppenheimer | Initiated | — | Outperform |
| Sep 18, 2013 | Summer Street Research | Initiated | — | Buy |